| Product Name: | Dimenhydrinate Injection IP |
| Brand Name: | Generic |
| Strength: | 50mg/ml |
| Dosage Form: | Liquid Injection |
| Route of Administration: | intramuscularly or intravenously |
| Packing: | 10 ampoules |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antihistamine |
| Indication: | Used for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness. It has a short duration of action of 4-8 hours. |
| Storage: | Store at 20 to 25°C (68″ to 77°F). see USP Controlled Room Temperature. Vial stoppers do not contain natural rubber latex. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
Dimenhydrinate Injection IP 50mg/ml
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Dimenhydrinate Injection IP 50mg/ml
Each ml contains
dimenhydrinate…….50 mg
benzyl alcohol………5%
propylene glycol……50%
Water for Injection……q.s.
Sodium hydroxide and/or hydrochloric acid may have been used to adjust pH.
THERAPEUTIC INDICATIONS:
Used for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness. It has a short duration of action of 4-8 hours.
CAUTION & SCHEDULE:
Schedule H drug
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
STORAGE:
Store at 20 to 25°C (68″ to 77°F). see USP Controlled Room Temperature.
Vial stoppers do not contain natural rubber latex.
DOSAGE:
As directed by physician.